Medical Devices and Life Science Tools

February 23, 2026

Buy ($175)

Companies covered: Stryker Corporation (NYSE:SYK), Intuitive Surgical, Inc. (NASDAQ:ISRG), Carlsmed, Inc. (NASDAQ:CARL), Glaukos Corp (NYSE:GKOS), Boston Scientific Corporation (NYSE:BSX), Enovis Corporation (NYSE:ENOV), Solventum Corporation (NYSE:SOLV), Hologic, Inc. (NASDAQ:HOLX), STAAR Surgical Company (NASDAQ:STAA), Organogenesis Holdings Inc. (NASDAQ:ORGO), Illumina, Inc. (NASDAQ:ILMN), Grail, Inc. (NASDAQ:GRAL), Guardant Health Inc. (NASDAQ:GH), EXACT Sciences Corporation (NASDAQ:EXAS), Danaher Corporation (NYSE:DHR), Thermo Fisher Scientific Inc (NYSE:TMO), Agilent Technologies, Inc. (NYSE:A), Waters Corporation (NYSE:WAT), Becton, Dickinson and Company (NYSE:BDX), Aclarion Inc. (NASDAQ:ACON), Alpha Tau Medical Ltd. (NASDAQ:DRTS), Butterfly Network, Inc. (NYSE:BFLY), Elutia Inc. (NASDAQ:ELUT), Epiminder Ltd. (ASX:EPI), HeartBeam, Inc. (NASDAQ:BEAT), Picard Medical Inc. (NYSEAMERICAN:PMI), SINTX Technologies Inc. (NASDAQ:SINT)